Malignant neoplasm (confirmed by pathology)
Conditions
Interventions
Intervention Group 1 (Group B):On the basis of routine care, take 1 sachet (10 g) of Konjac Tong product per day for three consecutive weeks.
Intervention Group 2 (Group C): On the basis of routine care, take 2 sachets (20 g) of Konjac Tong product per day for three consecutive weeks.
Blank Control Group (Group A) – Routine Care::Routine Care:After admission, provide both verbal and written information to patients and their families about the causes, common complications, and preve
instruct patients or their caregivers to learn and perform clockwise abdominal massage to assist in promoting intestinal peristalsis. During diarrhea-prone periods, recommend a low-fiber, easily diges
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age >= 18 years; (2) Patients with pathologically confirmed malignant tumors who are receiving radiotherapy, chemotherapy, or concurrent chemoradiotherapy; (3) Occurrence of constipation and/or diarrhea during radiotherapy/chemotherapy. Constipation is defined according to Rome IV criteria: spontaneous bowel movements (SBM) 3 times per day) compared with usual habit, loose or watery stools (BSFS type 5–7), increased water content (>85%), possibly accompanied by mucus, pus, blood, or undigested food; (4) Expected survival >= 3 months; (5) Normal cognitive and expressive abilities; (6) Voluntarily agree to participate in the study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Allergy to konjac or its derivative components; 2. Concurrent inflammatory bowel disease, Crohn's disease, or other intestinal disorders; 3. Recent use of potent laxatives (e.g., stimulant laxatives) that cannot be discontinued; 4. Mental disorders or long-term use of psychotropic medications; 5. Cognitive impairment or inability to comply with the study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of intestinal function;Improvement of constipation symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of sleep quality;Quality of life of cancer patients; | — |
Countries
China
Contacts
Public ContactHu hai
Sichuan Cancer Hospital
Outcome results
None listed